{
    "clinical_study": {
        "@rank": "109095", 
        "arm_group": [
            {
                "arm_group_label": "Magnetic - Oxygen", 
                "arm_group_type": "Experimental", 
                "description": "Magnetic and Oxygen Treatment for  Bell's Palsy"
            }, 
            {
                "arm_group_label": "prednisone - valacyclovir", 
                "arm_group_type": "Active Comparator", 
                "description": "prednisone and valacyclovir treatments for bell palsy"
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of this clinic trial is to testify the efficacy of using new and noninvasive\n      therapy, called simultaneous \"Magnetic and Oxygen Treatment along Meridians and Collaterals\"\n      (MOMC), to treat  Bell's Palsy."
        }, 
        "brief_title": "A Clinical Study on the Combined Magnetic and Oxygen Treatment for Bell's Palsy", 
        "completion_date": {
            "#text": "January 2005", 
            "@type": "Actual"
        }, 
        "condition": "Bell's Palsy", 
        "condition_browse": {
            "mesh_term": [
                "Bell Palsy", 
                "Facial Paralysis", 
                "Paralysis"
            ]
        }, 
        "detailed_description": {
            "textblock": "Between June 1998 and January 2005, a total of 3002 subjects with BP were evaluated, 882\n      patients fulfilled the inclusion criteria and entered the study.\n\n      Patients were randomly assigned to either the prednisone-valacyclovir group(group 1) or the\n      magnetic-oxygen group(group 2) . Among the 882 patients completing the study,825 patients in\n      group 1 received prednisone,  given as a single dose of 40 mg daily for 5 days; the dose\n      will then be reduced by 10 mg per 5 day, with a total treatment time of 20 days.while taking\n      valacyclovir 400 mg in three doses daily for 10 days. 57 patients in group 2 received\n      magnetic-oxygen treatment:MOMC treatment was given as daily 20 min section for 10 days with\n      2~3 days of intermission between;Oxygen therapy was given simultaneously at a flow rate of\n      2~3.0 L / min for the same duration during all acupuncture sections.\n\n      Clinical evaluation for the severity of paralysis was performed immediately before and after\n      the treatment using the facial nerve grading (FNG) scores of House and Brackmann system."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Only patients with complete (or nearly complete) non-recurrent facial paralysis\n             (grade 5-6/6) for more than 1 months\n\n          2. the first time to onset the disease\n\n          3. on one side of the face paralysis\n\n          4. willing to finish the whole observation period\n\n          5. with written consent form signed by themselves.\n\n        Exclusion Criteria:\n\n          1. facial palsy caused by other disease, such as infectivity multiple  radiculitis,\n             tumor which offend temporal bone, cerebral trauma\n\n          2. facial palsy combine diabetes, the severe disease of heart vessel, cerebral vessel,\n             liver, kidney, lung, and psychosis\n\n          3. patient with Hunt's syndrome\n\n          4. pregnant women or women in lactation\n\n          5. patients are participating other clinical research"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "74 Years", 
            "minimum_age": "10 Years"
        }, 
        "enrollment": {
            "#text": "882", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "August 28, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01686464", 
            "org_study_id": "wykq2012", 
            "secondary_id": "665533"
        }, 
        "intervention": [
            {
                "arm_group_label": "prednisone - valacyclovir", 
                "description": "patients were administered prednisone as a single dose of 40 mg daily for 5 days; the dose will then be reduced by 10 mg per 5 day, with a total treatment time of 20 days.while taking valacyclovir 400 mg in three doses daily for 10 days.", 
                "intervention_name": "prednisone and valacyclovir  treatments", 
                "intervention_type": "Drug", 
                "other_name": "prednisone and valacyclovir"
            }, 
            {
                "arm_group_label": "Magnetic - Oxygen", 
                "description": "MOMC treatment was given as daily 20 min section for 10 days with 2~3 days of intermission between. Oxygen therapy was given simultaneously at a flow rate of 2~3.0 L / min for the same duration during all acupuncture sections.", 
                "intervention_name": "Magnetic and Oxygen Treatment", 
                "intervention_type": "Device"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Prednisone", 
                "Valacyclovir", 
                "Acyclovir"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "magnetic", 
            "oxygen", 
            "Bell's Palsy", 
            "acupuncture"
        ], 
        "lastchanged_date": "September 12, 2012", 
        "link": {
            "description": "Bell palsy    paralysis     Acupuncture", 
            "url": "http://www.nlm.nih.gov/medlineplus/bellspalsy.html"
        }, 
        "location": {
            "facility": {
                "address": {
                    "city": "Xi'an", 
                    "country": "China", 
                    "state": "Shanxi", 
                    "zip": "710000"
                }, 
                "name": "the 4th Military Medical University"
            }
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "2", 
        "official_title": "A New Clinical Therapy for Bell's Palsy", 
        "overall_official": [
            {
                "affiliation": "Wenzhou Medical University", 
                "last_name": "yan L wang, Ph .D", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "The 4th military medical university", 
                "last_name": "Ping Li, M.D.", 
                "role": "Study Chair"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2005", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "House-Brackmann scale", 
            "safety_issue": "No", 
            "time_frame": "the 20th day of completion of the treatment"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01686464"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Wenzhou Medical College", 
            "investigator_full_name": "wang yanliang", 
            "investigator_title": "principal  investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "results_reference": [
            {
                "PMID": "7829945", 
                "citation": "Shafshak TS, Essa AY, Bakey FA. The possible contributing factors for the success of steroid therapy in Bell's palsy: a clinical and electrophysiological study. J Laryngol Otol. 1994 Nov;108(11):940-3."
            }, 
            {
                "PMID": "18368417", 
                "citation": "Finsterer J. Management of peripheral facial nerve palsy. Eur Arch Otorhinolaryngol. 2008 Jul;265(7):743-52. doi: 10.1007/s00405-008-0646-4. Epub 2008 Mar 27. Review."
            }
        ], 
        "source": "Wenzhou Medical University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Wenzhou Medical University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 1998", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2012"
    }
}